Worcester, MA – QuantHealth has announced the appointment of Flavio Dormont as Vice President of Scientific Strategy. About QuantHealth: QuantHealth is an AI company conducting patient-centric drug simulations to accelerate and de-risk drug development. Over 90% of drugs in clinical development stage fail to reach the market, which accumulates to a $45B/year direct lost to the pharma and biotech industry. Our platform allows our pharma and biotech partners to rapidly run thousands of variations of their clinical trials to optimize the trial design and significantly increase the probability of trial success, all while enabling discovery of new clinical opportunities and optimization strategies. QuantHealth has one the largest integrated datasets that spans the clinical, pharmacological and biological domains together with a proprietary AI platform that can predict patient-response to both approved and novel therapies.

For more information visit: https://quanthealth.ai/

QuantHealth
100 Front St. Suite #400 PMB1004
Worcester, MA 1608
Phone:
LinkedIn: https://www.linkedin.com/company/quanthealthlabs/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved